Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
about
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal healthUse of locally delivered dequalinium chloride in the treatment of vaginal infections: a reviewMechanisms and therapeutic effectiveness of lactobacilliVaginal and oral microbes, host genotype and preterm birthProbiotics--a helpful additional therapy for bacterial vaginosis.Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses.Socioeconomic disparities in ectopic pregnancy: predictors of adverse outcomes from Illinois hospital-based care, 2000-2006.Comparing the therapeutic effects of garlic tablet and oral metronidazole on bacterial vaginosis: a randomized controlled clinical trialGenomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health.The role of lactobacilli and probiotics in maintaining vaginal health.Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials.Treatment of bacterial vaginosis: what we have and what we miss.Identification and characterisation of vaginal lactobacilli from South African women.Biological control of vaginosis to improve reproductive health.Antibacterial treatment of bacterial vaginosis: current and emerging therapiesProbiotics to counteract biofilm-associated infections: promising and conflicting dataProbiotics: the potential for a live microbicide to prevent HIV.Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infectionScientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges.Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trialPurification and genetic characterization of gassericin E, a novel co-culture inducible bacteriocin from Lactobacillus gasseri EV1461 isolated from the vagina of a healthy woman.Behavioral predictors of colonization with Lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: a cohort studyEfficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial.Effects of processing and storage on Pediococcus pentosaceus SB83 in vaginal formulations: lyophilized powder and tabletsThe use of probiotic strains in caries prevention: a systematic review.Diversity of Vaginal Lactic Acid Bacterial Microbiota in 15 Algerian Pregnant Women with and without Bacterial Vaginosis by using Culture Independent Method.Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem: a review.Bacterial vaginosis: an update on diagnosis and treatment.Probiotic strategies for the treatment and prevention of bacterial vaginosis.Multi-species biofilms: how to avoid unfriendly neighbors.[Microbiota and probiotics: effects on human health].Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition.Influence of probiotics on Candida presence and IgA anti-Candida in the oral cavity.Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.Promising Prebiotic Candidate Established by Evaluation of Lactitol, Lactulose, Raffinose, and Oligofructose for Maintenance of a Lactobacillus-Dominated Vaginal Microbiota.Vaginal Mucosa and Drug DeliveryA Comparison of Dequalinium Chloride Vaginal Tablets (Fluomizin®) and Clindamycin Vaginal Cream in the Treatment of Bacterial Vaginosis: A Single-Blind, Randomized Clinical Trial of Efficacy and SafetyEuropean (IUSTI/WHO) guideline on the management of vaginal discharge, 2011Comparative efficacy of probiotic yoghurt and clindamycin in treatment of bacterial vaginosis in pregnant women: A randomized clinical trial
P2860
Q21129223-2248E194-31D6-4542-AF93-B476C6AF99F0Q26778387-43267917-232F-42D9-90A9-D896CCF9FCC7Q27012999-56E2BBD5-F906-45E3-B112-2A598F1492D2Q33631535-B3C58078-B976-4BE9-8C6C-ACCD2B0DE7D1Q33666121-D16B3344-7F10-4228-910F-7B0A9AE944A1Q33997785-B47DC79A-0407-4C66-B522-1F21A683803FQ34084694-7E969815-7220-45CF-827B-32B858021174Q34197409-7B249F77-7B61-4106-B745-C0AFB30D30AAQ34332869-57DF8EF1-A767-442F-B36E-51C501F97075Q34381043-30E69F68-DD20-4508-8BCD-B3167DA01CA6Q34390550-5BF5407B-94FA-4433-A58F-7D3E237C5511Q34407439-54C8AA29-3631-4B97-8078-44C02B200D43Q34564029-9D3ABAB1-24BF-48CC-9AE2-270B15751998Q35135297-70BA7DA8-0BA7-4FEA-8026-FD4596AAB704Q35235235-27032E06-DE3B-445C-88D0-2C9480A6C2E1Q35278680-900035A5-4607-46E8-8326-0C7C5B32AEB9Q35575903-994FB108-1231-4C1B-812C-560ED1F49194Q35681666-44D2DA5E-A235-4EC8-8DB2-5BE225771A2BQ35800667-9D0C6BE5-5A39-4709-9289-183A8533DFE0Q35860581-7FF3F08D-A81F-4CC8-9F99-2ADDF9650D70Q35954740-F1211360-192B-4673-9328-6CE8582186E2Q36014400-E83BDF60-4002-48E5-B424-132D18544A1AQ36110963-4BB7E814-332F-43DD-9DDF-35B3FEDEE048Q36988564-9B747B40-0941-438E-AA0D-A6DA1BA28F94Q37083793-08A27AA5-6B4B-4AE9-AC24-7D4FA9BE6A7EQ37352938-A18F006E-3A48-443B-9515-2323FBC5E87AQ37611334-8CFA8AE4-0F5A-42FD-B5D3-2544E177B895Q37626068-1F4D9EF7-CF98-4D23-90B8-707068F07D29Q37809873-68E988C4-9076-4B38-84CF-185EBC680AFFQ37978400-85E003D9-FF69-4E7C-9097-3B26F131AB7EQ39281119-42FCDC3E-EC49-49A0-BE6A-40A7A66C3D93Q40254597-4B0F251C-5781-4EBD-A887-A37FC2144FDAQ42004100-492BDE71-B6FD-4D94-AE53-DD7C70D9D727Q46084042-59743B26-3118-4137-B248-77AFD4AC42A7Q47561074-B379CFF3-52DD-45CD-806C-59FE2C4C6D4EQ57570821-10DC9265-7163-4A3E-BB8D-E3BD1EA8CBFBQ57703148-EBB9F48D-EE79-4238-ABA8-FD53759D1DD8Q57703162-D7DD60EC-C36F-420D-8263-19E4150BBF77Q59168507-5B46F4B3-596B-41C3-9ACE-A963160C50D3
P2860
Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Human lactobacilli as suppleme ...... zed, placebo-controlled study.
@ast
Human lactobacilli as suppleme ...... zed, placebo-controlled study.
@en
Human lactobacilli as suppleme ...... zed, placebo-controlled study.
@nl
type
label
Human lactobacilli as suppleme ...... zed, placebo-controlled study.
@ast
Human lactobacilli as suppleme ...... zed, placebo-controlled study.
@en
Human lactobacilli as suppleme ...... zed, placebo-controlled study.
@nl
prefLabel
Human lactobacilli as suppleme ...... zed, placebo-controlled study.
@ast
Human lactobacilli as suppleme ...... zed, placebo-controlled study.
@en
Human lactobacilli as suppleme ...... zed, placebo-controlled study.
@nl
P2093
P2860
P356
P1433
P1476
Human lactobacilli as suppleme ...... zed, placebo-controlled study.
@en
P2093
Kjeld R Ryttig
Per-Göran Larsson
Stig Larsen
P2860
P2888
P356
10.1186/1472-6874-8-3
P577
2008-01-15T00:00:00Z
P5875
P6179
1005792714